Thyme Care’s Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health. The post Thyme Care Raises $125M, Launches New Oncology Parent Entity appeared first on MedCity News.
In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — eating food with gluten to see if it prompts an immune response. There are currently no FDA-approved drugs for celiac disease, but Teva’s antibody is part of a competitive race to bring patients the first one….
[Sponsored] We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring. The post Automation Didn’t Dehumanize Care. Bad Systems Did. appeared first on MedCity News.
Isolated improvements rarely translate into enterprise-wide transformation when they are layered onto outdated, inefficient workflows instead of being integrated into redesigned care delivery. The post The Healthcare Inflection Point: AI Can’t Fix 1990s Technology appeared first on MedCity News.
By MIKE MAGEE The world of medical science largely closed ranks last month in defense of Tony Fauci. Dr. Fauci had been hauled before the Senate Homeland Security Committee to face hostile entrapment by long time critique Senator Rand Paul of Kentucky. Taking no chances, his lawyers had the former head of NIH’s Infectious Disease…
Cushla and Clirinx, two Irish startups, are merging to give rare disease patients one continuous health and research record. The deal will pair Cushla’s patient-controlled EHR with Clirinx’s unique patient ID system so data no longer gets lost between doctors, hospitals and clinical trials. The post This Merger Wants to Prevent Rare Disease Patients from…
HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services. The post HHS Provides $77M in Grants for Substance Use Prevention, Mental Health appeared first on MedCity News.
Former ONC chief adjusts Mayo’s AI governance process to meet the increase in volume and complexity of solutions
GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s recently approved mRNA flu shot, which addresses just one of those proteins. The post GSK’s Pivotal Test for mRNA Flu Vaccine Aims to Show Two…
Join us for an upcoming Healthcare Innovation San Diego Summit panel exploring what’s real, what’s working and what healthcare leaders need to consider as AI moves from experimentation to action.